Roongroj Bhidayasiri, Jirada Sringean, Saisamorn Phumphid, Chanawat Anan, Chusak Thanawattano, Suwijak Deoisres, Pattamon Panyakaew, Onanong Phokaewvarangkul, Suppata Maytharakcheep, Vijittra Buranasrikul, Tittaya Prasertpan, Rotjana Khontong, Priya Jagota, Araya Chaisongkram, Worawit Jankate, Jeeranun Meesri, Araya Chantadunga, Piyaporn Rattanajun, Phantakarn Sutaphan, Weerachai Jitpugdee, Marisa Chokpatcharavate, Yingyos Avihingsanon, Chanchai Sittipunt, Werasit Sittitrai, Grisada Boonrach, Aekamorn Phonsrithong, Pichit Suvanprakorn, Janprapa Vichitcholchai, Tej Bunnag
The rising prevalence of Parkinson's disease (PD) globally presents a significant public health challenge for national healthcare systems, particularly in low-to-middle income countries, such as Thailand, which may have insufficient resources to meet these escalating healthcare needs. There are also many undiagnosed cases of early-stage PD, a period when therapeutic interventions would have the most value and least cost. The traditional "passive" approach, whereby clinicians wait for patients with symptomatic PD to seek treatment, is inadequate...
2024: Frontiers in Neurology